Kainkaryam Raghunandan M, Woolf Peter J
Department of Chemical Engineering, University of Michigan, Ann Arbor, MI 48109, USA.
Curr Opin Drug Discov Devel. 2009 May;12(3):339-50.
Pooling in HTS refers to the act of testing mixtures of compounds in a primary screen to accurately identify hits for secondary screening. The reduction in the number of tests needed to screen a compound library by pooling can also be extended to achieve much-needed error tolerance in HTS. Despite the success of HTS in other biological experiments, pooling in high-throughput drug screening has been a controversial and often marginalized paradigm. At first appearance, pooling appears to promise gains from reduced effort, or possibly could create more problems than solutions. However, this article demonstrates that pooling is a practical and necessary part of HTS: discussions include the rationale for pooling compounds in HTS, a unifying view of pooling design theory, a review of past attempts at pooling and their success, and recent advances in the field.
高通量筛选(HTS)中的混合指的是在初次筛选中对化合物混合物进行测试,以准确识别用于二次筛选的活性物质。通过混合来筛选化合物库所需测试次数的减少,也可用于在高通量筛选中实现急需的容错能力。尽管高通量筛选在其他生物学实验中取得了成功,但在高通量药物筛选中,混合一直是一个有争议且常被边缘化的模式。乍一看,混合似乎有望通过减少工作量而有所收获,或者可能带来的问题比解决的问题更多。然而,本文表明混合是高通量筛选中切实可行且必要的一部分:讨论内容包括在高通量筛选中混合化合物的基本原理、混合设计理论的统一观点、对过去混合尝试及其成功情况的回顾,以及该领域的最新进展。